A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Pneumagen has announced the publication of phase 2 data showing its antiviral therapy, Neumifil, significantly reduced ...

Understanding the differences between colds, flu, and RSV can help in identifying the illness you're dealing with, the ...

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu ...